Affymetrix Inc. (AFFX)
-NasdaqGS | Prev Close: | 3.67 |
|---|
| Open: | N/A |
|---|
| Bid: | 3.52 x 100 |
|---|
| Ask: | 3.72 x 300 |
|---|
| 1y Target Est: | 4.89 |
|---|
| Beta: | 1.07 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 2.96 - 5.50 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 658,036 |
|---|
| Market Cap: | 260.93M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.31 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CFO Moves: Tellabs, Affymetrix, QLogicat The Wall Street Journal(Mon, May 20)
- AFFYMETRIX INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Mon, May 20)
- Affymetrix CFO Barabe to retire in JuneAP(Mon, May 20)
- Affymetrix Appoints Gavin Wood as Executive Vice President and Chief Financial OfficerBusiness Wire(Mon, May 20)
- Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013at Seeking Alpha(Mon, May 13)
- AFFYMETRIX INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other EventsEDGAR Online(Fri, May 10)
- AFFYMETRIX INC FinancialsEDGAR Online Financials(Tue, May 7)
- AFFYMETRIX INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 1)
- Affymetrix Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- Affymetrix Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet(Tue, Apr 30)
- Affymetrix Earnings Call scheduled for 5:00 pm ET todayCCBN(Tue, Apr 30)
- Affymetrix Reports 2013 First Quarter ResultsBusiness Wire(Tue, Apr 30)
- Is Illumina's Stock Destined for Greatness?at Motley Fool(Tue, Apr 30)
- AFFYMETRIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, Apr 30)
- Q1 2013 Affymetrix Earnings Release - After Market CloseCCBN(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 45.88 |
|---|
| P/S (ttm): | 0.85 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.01 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.00 |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 11.33 |
|---|
Business Summary
Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia.
View More